Pharma News
subscribe to this feed RSS

videoCramer: Abbott’s a Growth Stock

March 11th, 2010 |  Read the full story

BioSante rallies on study; drug stocks slip

March 11th, 2010 |  Read the full story

How Many Reps Visit A Doctor’s Office Each Week?

March 11th, 2010 |  Read the full story

Facet Biotech Has $722M That Says It Pays to Stand Up to Bullies

March 11th, 2010 |  Read the full story

Merck joins consortium on vax plant

March 11th, 2010 |  Read the full story

Aveo Pharma delays IPO, at least briefly

March 11th, 2010 |  Read the full story

Bay Area biotech blueprints $100M China biologics hub

March 11th, 2010 |  Read the full story

BioSante shares surge as cancer vax performs in small study

March 11th, 2010 |  Read the full story

Basilea mounts last-ditch effort to gain quick ceftobiprole OK

March 11th, 2010 |  Read the full story

Nabi Biopharmaceuticals logs revenue from Glaxo sale

March 11th, 2010 |  Read the full story

Chelsea Therapeutics 4Q loss narrows on costs

March 11th, 2010 |  Read the full story

Obamacare? Who Cares? There Are Drug Deals To Do

March 11th, 2010 |  Read the full story

Drug Safety, Social Media & A Universal Symbol

March 11th, 2010 |  Read the full story

AstraZeneca Teams Up With India’s Torrent in Generics

March 11th, 2010 |  Read the full story

Sanofi-aventis Successfully Completes The Acquisition of Chattem, Inc

March 11th, 2010 |  Read the full story

Did J&J Plan to Break Rules?

March 11th, 2010 |  Read the full story

At Novartis, It’s Pregnant Women vs. Cheerleaders Among the Sales Reps

March 11th, 2010 |  Read the full story

Merck’s Stromectol Wipes Out Hard-to-Treat Lice, Study Finds

March 11th, 2010 |  Read the full story

10 Biotech Stocks On the Line

March 11th, 2010 |  Read the full story

StemCells pares 4Q loss after acquisition

March 11th, 2010 |  Read the full story

No+No=Yes: Pirfenidone and the Power of Orphan Drugs

March 11th, 2010 |  Read the full story

FDA to Review Bone Drugs After Studies Report Hip Breaks

March 11th, 2010 |  Read the full story

Pioneering sequencing projects unveil triggers for disease

March 11th, 2010 |  Read the full story

Pioneering personal sequencing projects unveil disease triggers

March 11th, 2010 |  Read the full story

InterMune’s Lung Drug Gets Backing From FDA Panel

March 10th, 2010 |  Read the full story

A Tale Of Two Sectors

March 10th, 2010 |  Read the full story

Biotechs Jump on Facet, Intermune Deal

March 10th, 2010 |  Read the full story

Abbott wins OK for cataract lens implant

March 10th, 2010 |  Read the full story
« Older Entries